Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study

AIMS: To describe heparin dosing requirements in patients who underwent catheter ablation of atrial fibrillation with uninterrupted anticoagulation using dabigatran etexilate (dabigatran) or warfarin to attain therapeutic activated clotting time (ACT) in the RE-CIRCUIT(®) study. The RE-CIRCUIT study...

Descripción completa

Detalles Bibliográficos
Autores principales: Calkins, Hugh, Willems, Stephan, Verma, Atul, Schilling, Richard, Hohnloser, Stefan H, Okumura, Ken, Nordaby, Matias, Kleine, Eva, Bis, Branislav, Gerstenfeld, Edward P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781146/
https://www.ncbi.nlm.nih.gov/pubmed/30982849
http://dx.doi.org/10.1093/europace/euz057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781146/
https://www.ncbi.nlm.nih.gov/pubmed/30982849
http://dx.doi.org/10.1093/europace/euz057

Ejemplares similares